Navigation Links
Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference
Date:6/2/2008

SAN FRANCISCO, June 2 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Canada), announced today that David H. Kirn, M.D., President & CEO delivered a plenary session presentation on Friday, May 30, 2008 entitled "Clinical Proof-of-Concept with JX-594, a Novel Targeted Multi-Mechanistic Oncolytic Poxvirus, in Patients with Refractory Liver Tumors" at the American Society of Gene Therapy (ASGT) Annual Meeting in Boston, Massachusetts. This abstract was selected for presentation in the plenary session from over 1,000 abstracts submitted to the conference. The ASGT Meeting is the premier annual international conference covering advancements in viral and genetic therapies for cancer.

In addition, Dr. John C. Bell, Chief Scientific Officer, delivered a presentation at the same conference, on Thursday, May 29, 2008, entitled "Oncolytic Virus Therapies of Cancer." In a third presentation by Jennerex R and D leaders, Dr. Kirn delivered a presentation on Jennerex product development entitled "Design and Development of Targeted and Armed Oncolytic Poxviruses, a Novel Therapeutic Class."

This follows on Jennerex's recent announcement that Phase I clinical trial results from its first-in-class lead product JX-594 were published in the premier journal Lancet Oncology. The majority of these end-stage patients with solid tumors had objective tumor destruction and responses following treatment with the cancer biotherapeutic. Half of the JX-594-treated patients survived for more than eight months, well beyond their life expectancies of three to four months, and four patients with tumor responses survived for 11 to over 18 months. Results were especially promising for liver and lung cancer patients. Importantly, treatment with JX-594 was shown to be well-tolerated. A Phase II clinical trial is now underway for JX-594 in liver cancer. The world-wide liver cancer market is estimated at over one billion dollars per year.

About JX-594

JX-594
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...RNewswire/ -- Major League Baseball,s Mark Teahe...ls and recently acquired by the Chicago White Sox,...ard is given annually to a Major League Baseball p...dedication of baseball great Fred Hutchinson, both...dlands, Calif., native made his MLB debut with the...
(Date:11/30/2009)...esidents of ,stroke belt, study finds , ...orn in the "stroke belt" of the southern United St...e than others, even if they live elsewhere later, ...te people born in the North and South Carolina, Ge...a show a consistently higher incidence of stroke c...
(Date:11/30/2009)... notes a rise in child deaths linked to flu, , .... health officials said Monday that H1N1 swine flu...ven as the number of American children dying from ...ort, released Monday by the U.S. Centers for Disea...s to doctors for influenza-like illness nationally...
(Date:11/30/2009)...ov. 30 Jedi Mind, Inc ....sed to announce the Company,s first thought-contro...The game, "Think-Tac-Toe" is the first of its kind...power of their mind and is geared towards people o...e of $49 and can be purchased directly through the...
(Date:11/30/2009)...land, Nov. 30 Tyco Inter...its 2010 annual general meeting of shareholders wi...m. Central European time at the Park Hyatt Zurich ...and. Registered shareholders as of January 11, 201...e annual general meeting. Additionally, individua...
Breaking Medicine News(10 mins):Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2
...if., Jan. 12 ,Watson Pharmaceuticals, Inc. (NYSE: ...X ) announced today that they have entered into Se... patent litigation related to Warner Chilcott,s,or...,to Warner Chilcott,s Femring(R) product and Licen...
... into the healthcare IT and government services ma...Y., Jan. 12 Oleen Pinnacle Healthcare Consulting ...n Health Systems (PHS), a Central New York-based I...nt sectors. , , "We,re very excited about the pos...
...Jan. 12 /PRNewswire-FirstCall/ - DiagnoCure Inc. (... high-value cancer diagnostic tests and delivering...agnoCure Oncology Laboratories based in West Chest...y 15th in San Francisco, California. The Company i...
..., , MOUNT OLIVE, N.J., Jan 12 InSet Technologies...mable implantable pumps for targeted delivery of m...inancing totaling $25 million. , , Clarus Venture...ncing, Kurt C. Wheeler of Clarus Ventures will joi...
...ause you are traveling or,on holiday doesn,t mean ...ts.,In fact, it is an easier time to be healthy. ,...20071212/NYWFNS2 ) , Many Americans take to th...and prepackaged snacks, or extravagant and excessi...
...lthcare Technology will be holding a developers su...eTesting 2.0 with their software platform. , ...nalysts and industry-watchers believe that cloud c...e companies. , , ,Amistaff Healthcare Technology, ...
Other Medicine News:Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 2Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 3Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 4Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 5Health News:Oleen Pinnacle Announces Acquisition of Partners in Health Systems 2Health News:Previstage(TM) GCC to be presented at ASCO GI 2Health News:Previstage(TM) GCC to be presented at ASCO GI 3Health News:Previstage(TM) GCC to be presented at ASCO GI 4Health News:InSet Technologies Completes $25 Million Financing 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 3Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 4Health News:NurseTesting 2.0 Goes to the Clouds and Invites Developers to Summit 2Health News:NurseTesting 2.0 Goes to the Clouds and Invites Developers to Summit 3
(Date:11/30/2009)..., Nov. 30 Reportlinker.com announc...in its catalogue: ,, Inflammatory Disorders: T...nse ,, http://www.reportlinker.com/p0165600/I...alance-the-Immune-Response.html ,, The human i...vidual body or producing an exaggerated response t...
(Date:11/30/2009)... Mass., Nov. 30 According to Mille...n medical technology market intelligence, the near...clined by almost 5% over 2008 as patients chose to...omic crisis. The market will, however, begin recov...g pre-recession growth rates of over 15%. MRG,s fa...
(Date:11/30/2009)...d CHICAGO, Nov. 30 Today at the 95... Radiological Society of North America (RSNA), Bay...nrollment of the first patient in an international... and safety of florbetaben (BAY 94-9172) PET imagi... brain, which are a pathological hallmark of Alzhe...
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3The right messenger for a healthy immune response 9284 1The right messenger for a healthy immune response 9284 2Chasing tiny vehicles 9282 1Chasing tiny vehicles 9282 2Chasing tiny vehicles 9282 3Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3
...NEW HAVEN, Conn., Aug. 5 Rib-X Pharmaceuticals, I...e company focused on the,discovery and development...tic-resistant infections, announced today that com...s at two conferences this,week., Gordon Research ...hoke Bhattacharjee, Ph.D, Senior Scientist, presen...
...WHIPPANY, N.J., Aug. 5 Nexgen Spine, a leading,de...ical treatment of,degenerative disc disease, annou...o market the Physio-L(R) Lumbar Artificial Disc in...Physio-L(R) Artificial Disc Prosthesis has,receive...President and CEO,of Nexgen Spine. "This represent...
Other Medicine Technology:Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 2Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 3Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: